Chengdu Hyperway Pharmaceuticals Co., Ltd.

Chine

 
Quantité totale PI 13
Rang # Quantité totale PI 117 395
Note d'activité PI 2,1/5.0    16
Rang # Activité PI 52 941

Brevets

Marques

3 0
2 0
8 0
0
 
Dernier brevet 2024 - Pak4 kinase inhibitor, and prepa...
Premier brevet 2021 - Compound serving as btk inhibito...

Derniers inventions, produits et services

2023 Invention Pak4 kinase inhibitor, and preparation method therefor and use thereof. The present invention rel...
Invention Pharmaceutical composition containing glp-1 receptor agonist analog. The present invention provid...
Invention Benzylamine or benzyl alcohol derivative and uses thereof. The present invention discloses a com...
Invention Fused ring compound, pharmaceutical composition containing same, and use of fused ring compound. ...
2021 Invention Pyrrole derivative, and preparation method and use therefor. Provided are a pyrrole derivative an...
Invention Benzylamine or benzyl alcohol derivative and use thereof. The present invention discloses a compo...
Invention Benzylamine or benzyl alcohol derivative and use thereof. Disclosed are a compound as a sodium ch...
Invention Compound as pak4 kinase inhibitor, and preparation method therefor and application thereof. The p...
Invention Compound as brain-permeable btk or her2 inhibitor, preparation method therefor, and use thereof. ...
Invention Compound serving as btk inhibitor, preparation method therefor, and use thereof. A compound serv...
Invention Compound serving as btk inhibitor, preparation method therefor, and use thereof. 12345655 or N, a...
Invention Compound serving as btk inhibitor, preparation method therefor, and use thereof. A compound servi...